COVID-19 Records

Fauci Awards Package (Redacted) — page 59

of 136 pages

← p.58 p.60 → · this page in the original PDF · package

phone: I mobile: I email: @nih.gov https://www.niaid.nih.gov/about/vrc From: "Mascola, John (NIH/VRC) [E]" < @mail.nih.gov> Date: Monday, March 1, 2021 at 9:37 PM To: "Koup, Richard (NIH/VRC) [E]" < @mail.nih.gov>, "Graham, Barney (NIH/VRC) [E]" < @mail.nih.gov>, "Ledgerwood, Julie (NIH/NIAID) [E]" < @nih.gov>, Karin Bok @nih.gov> Cc: "Sitar, Sandra (NIH/VRC) [C]" < @mail.nih.gov> Subject: FW: - FYI. We should each review and then discuss. Thanks, John From: Fauci, Anthony (NIH/NIAID) [E] < @niaid.nih.gov> Sent: Monday, March 1, 2021 6:07 PM To: Mascola, John (NIH/VRC) [E] < @mail.nih.gov> Cc: Lane, Cliff (NIH/NIAID) [E] < @niaid.nih.gov> Subject: FW: - Let us discuss. Anthony S. Fauci, MD Director National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda, MD Phone: FAX: E-mail: @niaid.nih.gov The information in this e-mail and any of its attachments is confidential and may contain sensitive information. It should not be used by anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete it from your mailbox or any other storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender's own and not expressly made on behalf of the NIAID by one of its representatives. From: Weissman, Drew < @pennmedicine.upenn.edu> Sent: Monday, March 1, 2021 5:21 PM To: Fauci, Anthony (NIH/NIAID) [E] < @niaid.nih.gov> Subject: Re: - Tony, Here is the human dose IM studies in pregnant mice. We still have some concern over the data and are talking to all of the appropriate people.

This is our OCR of the page, with running headers and footers removed. The Committee's PDF is authoritative; quote from it. Machine-readable, including the uncleaned text: /api/page/fauci_awards/59

Records on this page

RecordDateTypePages
Re: - 2021-03-01 email 59–60
FW: - 2021-03-01 email 59
FW: - 2021-03-01 email 59
FW: - 2021-03-02 email 58–59